GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
1.680
-0.069 (-3.97%)
At close: Aug 13, 2025, 4:00 PM
1.680
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:00 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $5.29 million as of August 13, 2025. Its market cap has increased by 35.61% in one year.
Market Cap
5.29M
Enterprise Value
2.99M
1-Year Change
35.61%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $5.29M, a decrease of -93.64%. That is a compound annual growth rate of -31.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 4.50M | -33.82% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |